Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STREAM: The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

NCT02409290 is registered in ClinicalTrials.gov with IUATLD, Inc as lead sponsor.

NCT NCT02409290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02409290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STREAM: The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB
Lead sponsor
IUATLD, Inc
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2016
Completion date
May 2, 2023
Enrollment
588 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

mdr-tb